AURAPEP RESEARCH LIBRARY
Compound & Pathway Profiles
Evidence-led profiles of research compounds and the biological pathways studied around them.
20 articles
Compound & Pathway Profiles
Amylin, GLP-1 and Combination Metabolic Research
Why amylin and GLP-1 pathways are studied together, what combination trials can show, and why evidence cannot be transferred between molecules or blends.
Compound & Pathway Profiles
Cagrilintide Research: Amylin Signalling and Emerging Evidence
What cagrilintide is designed to study, how amylin signalling differs from incretin signalling, and why its evidence remains investigational.
Compound & Pathway Profiles
Tirzepatide Research: Dual GIP/GLP-1 Receptor Signalling
How tirzepatide engages GIP and GLP-1 receptors, what clinical trials have reported, and why dual agonism must be evaluated as a complete molecule.
Compound & Pathway Profiles
Semaglutide Research: GLP-1 Receptor Signalling and Clinical Evidence
How semaglutide has been studied as a pharmaceutical GLP-1 receptor agonist—and why those findings remain specific to the tested drug and formulation.
Compound & Pathway Profiles
GHK-Cu Research: Copper Binding, Skin Biology and Evidence Limits
What cell, animal and small topical human studies can establish—and what they cannot establish about other formulations or uses.
Compound & Pathway Profiles
BPC-157 Research: Preclinical Findings and the Human Evidence Gap
What laboratory and animal studies have investigated, how little human evidence exists, and why the gap matters.